Helfant, R.H. , Bodenheimer, M.M., Banka, V.S.: Asynergy in coronary heart disease. Evolving clinical and pathophysiologic concepts. Ann. Intern. Med. , 87: 475, 1977.
2.
Dyke, S.H., Cohen, P.F., Gorlin, R., et al.: Detection of residual myocardial function in coronary artery disease using postextrasystolic potentiation. Circulation , 50: 694, 1974.
3.
McAnulty, J.H. , Hattenhauer, M.T., Rosch, J., et al.: Improvement in left ventricular wall motion following nitroglycerin. Circulation, 51: 140, 1975.
4.
Feigenbaum, H.: Echocardiography. Philadelphia, Lea and Febiger, 1972, p. 99.
5.
Gould, L., Reddy, C.V.R.: Oral therapy with phentolamine in chronic congestive heart failure. Chest, 75: 487, 1979.
6.
Chatterjee, K., Swan, H.J.C., Parmley, W.W., et al.: Depression of left ventricular function due to acute myocardial ischemia and its reversal after aortocoronary saphenous vein bypass. N. Engl. J. Med., 286: 1117, 1972 .
7.
Herman, M.V. , Heinde, R.A., Klein, M.D., et al.: Localized disorders in myocardial contraction: Asynergy and its role in congestive heart failure. N. Engl. J. Med., 277: 222, 1967.
8.
Gould, L., Zahir, M., Ettinger, S.: Phentolamine and cardiovascular performance. Br. Heart J. , 31: 154, 1969.
9.
Miller, R.R. , Vismara, L.A., Williams, D.O., et al.: Pharmacologic mechanism for left ventricular unloading in clinical congestive heart failure: Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation. Circ. Res., 39: 127, 1976.
10.
Braunwald, E., Ross, J., Jr., Sonnenblick , E.H.: Mechanisms of contraction of the normal and failing heart. N. Engl. J. Med., 277: 794, 1967.
11.
Bagnell, E.E. , Hilliard, C.C., Daniell, H.B., et al.: Studies on the inotropic mechanism of phentolamine. Am. J. Cardiol., 25: 83, 1970.
12.
Gould, L., Reddy, C.V.R., Blatt, C.J., et al.: Phentolamine, effects on coronary blood flow in humans with recent myocardial infarction. Br. Heart J., 37: 647, 1975.
